Novo Nordisk has raised alarm about safety concerns related to compounded versions of its semaglutide-based drugs, Wegovy and Ozempic. The pharmaceuticals giant acknowledged reports of 10 deaths and ...

Ranvir remarked: "Ozempic is always in the papers - either its a miracle drug or they've got a great PR team! " To which Dr Hilary responded: "It's getting a lot of attention isn't it? " before ...

Novo Nordisk disclosed it knows of 10 deaths and 100 hospitalizations from people taking compounded copies of its weight loss ...

James Manning / PA Images / Getty Images After rising in premarket trading, Novo Nordisk's U.S.-listed shares fell after the ...

Novo Nordisk said on Wednesday it was aware of reports of 10 deaths and 100 hospitalisations of people who had taken compounded copies of its weight-loss and diabetes drugs. U.S. regulations allow ...

Ozempic sales were a bit lower than expected in the quarter at DKK 29.8 billion, while Wegovy sales were higher at DKK 17.3 ...

Novo Nordisk's Q3 2024 report highlights a 21% YoY sales increase with strong gains in GLP-1 diabetes and obesity drugs but ...

Novo Nordisk reported better-than-expected third-quarter sales for its weight-loss drug Wegovy, calming investor concerns ...

Novo Nordisk is the company that makes the Ozempic and Wegovy drugs, part of the wildly popular GLP-1 class of drugs that have proven effective in reducing weight and treating diabetes. Demand has ...

Queen and American Idol star Adam Lambert revealed he has lost 60lbs and says it happened after switching from Ozempic.

In India, the drug is not licensed for weight loss. but as anti-diabetic medication, warns Dr Chandrakant Lahariya.